STOCK TITAN

Smith & Nephew plc (SNN) Stock News, Jan-Jul 2021

SNN NYSE

Smith & Nephew plc reports news as a global medical technology company focused on the repair, regeneration and replacement of soft and hard tissue. Coverage centers on Orthopaedics, Sports Medicine & ENT and Advanced Wound Management, including wound dressings, negative pressure wound therapy, cartilage and rotator cuff repair implants, orthopedic reconstruction, trauma and extremities products, and surgical robotics.

Recurring developments include product launches and clinical evidence for ALLEVYN COMPLETE CARE, RENASYS EDGE, CARTIHEAL AGILI-C, REGENETEN, CORI, AETOS and related platforms; conference showcases; distribution agreements; segment performance updates; share buybacks; and governance matters tied to the company’s London-listed shares and NYSE-traded ADRs.

Rhea-AI Summary

Smith+Nephew (NYSE:SNN) has launched the FAST-FIX FLEX Meniscal Repair System, a breakthrough device featuring a surgeon-guided, bendable needle that enhances access to all meniscal zones. This innovation potentially increases repair rates over removal, addressing over 400,000 procedures annually in the U.S. The system boasts a 25% reduction in needle insertion area and stronger repairs. It is designed to improve procedural efficiency and minimize the need for incisions, ultimately aiming to shift the standard of care from meniscectomy to meniscal repair.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.5%
Tags
none
-
Rhea-AI Summary

Smith+Nephew (NYSE:SNN) has launched ARIA Home PT, a remote physical therapy solution that enhances patient care by providing customized experiences and actionable data. The product significantly reduces healthcare costs, with an average savings of $2,745 per patient, while decreasing readmissions (60%) and outpatient visits (86%). ARIA Home PT leverages advanced technology and telehealth, improving patient adherence by 35% and achieving a Net Promoter Score of 90.3. The launch addresses growing demand for physical therapy amid a projected therapist shortage by 2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.75%
Tags
none
-
Rhea-AI Summary

Smith+Nephew (NYSE:SNN) published research indicating that 45% of clinicians believe their patients with chronic wounds would benefit from more involvement in their care, which can free up time for additional patients. The study, published in Wounds International, highlighted the role of COVID-19 in increasing remote care and patient engagement through digital tools. Despite positive feedback about shared care approaches in regions like the USA and UK, clinicians expressed the need for support in identifying suitable patients for shared care. The research involved 511 healthcare practitioners globally.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.02%
Tags
covid-19
Rhea-AI Summary

Smith+Nephew (LSE: SN, NYSE: SNN) announces a study demonstrating that its computer-guided technology for total hip arthroplasty (THA), known as RI.HIP NAVIGATION, significantly lowers revision rates and enhances patient satisfaction. Utilizing the National Joint Registry of England, Wales, and Northern Ireland, the study found a 55% lower risk of revision at ten years (1.06% vs. 3.88% for conventional THA). Higher patient satisfaction rates were also reported in the computer-guided group. This technology aims to improve long-term outcomes for patients undergoing hip replacement.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.06%
Tags
none
-
Rhea-AI Summary

Smith+Nephew (NYSE:SNN) announces the launch of DOUBLEFLO Inflow/Outflow Pump and 4KO (Optimized) Arthroscopes and Laparoscopes, enhancing the INTELLIO Connected Tower Solution. The DOUBLEFLO Pump is remotely controllable, allowing surgeons to focus on patients during procedures. The 4KO Scopes promise a 30% increase in image resolution, supporting multi-specialty centers. Both products are now available in the US and Europe, aimed at improving surgical performance and capital investment value.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.48%
Tags
none
-
Rhea-AI Summary

Smith+Nephew (LSE:SN, NYSE:SNN) announced that its LEAF Patient Monitoring System has monitored over 60,000 patients, accumulating more than 7 million hours of use. This system aims to reduce hospital-acquired pressure injuries (HAPIs), which have risen in the U.S., costing an average of $21,767 per patient. Clinical trials indicated a 73% reduction in HAPI odds, potentially saving up to $39 billion nationally. By implementing the LEAF System, healthcare facilities have raised patient repositioning adherence from under 50% to as high as 98%, enhancing patient care and reducing costs.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.65%
Tags
none
Rhea-AI Summary

Smith+Nephew (LSE:SN, NYSE:SNN) has announced a marketing collaboration with Movendo Technology to enhance its Real Intelligence ecosystem with personalized robotic rehabilitation capabilities. This collaboration, initiated in Europe, focuses on Movendo's HUNOVA rehabilitation device, which analyzes biomechanics to create individualized recovery programs. This partnership aims to improve patient outcomes through integrated robotics-assisted surgery and rehabilitation. The CORI Surgical System will also launch in Europe after its successful introduction in the U.S. in 2020.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.04%
Tags
none
-
Rhea-AI Summary

Smith+Nephew (NYSE:SNN) announced a real-world study from Spain showing that their ALLEVYN LIFE Foam Dressings significantly reduced dressing change frequency by 47.1% and weekly dressing costs by 58.7%. Conducted across 24 primary care centers and six nursing homes, the study included 94 patients with a median age of over 70. Healthcare professionals noted improved patient satisfaction and treatment experiences despite fewer nursing visits, showcasing ALLEVYN LIFE's effective exudate management and cost efficiency in wound care.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.41%
Tags
none
-
Rhea-AI Summary

Smith+Nephew (LSE:SN, NYSE:SNN) announced a new publication highlighting that its PICO Single Use Negative Pressure Wound Therapy System (sNPWT) reduces surgical site infections (SSIs) by 63%, seroma by 77%, and dehiscence by 30%. The systematic review covered 29 studies with 5,614 patients, demonstrating the therapy's efficiency across various surgical specialties. The PICO sNPWT also decreases hospital stay length by nearly 2 days, potentially benefiting healthcare systems significantly. This evidence supports PICO therapy for preventing surgical complications effectively.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.19%
Tags
none
Rhea-AI Summary

Smith+Nephew (NYSE: SNN) has successfully launched a new inventory automation solution in partnership with Movemedical in the US. This platform aims to simplify field sales operations for better inventory management, ensuring timely product delivery to customers. The solution enhances logistics and real-time data access, empowering sales teams to meet customer needs effectively. Smith+Nephew integrated this system across its entire US Orthopaedic sales force in just over a week, highlighting its operational efficiency.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.6%
Tags
partnership

FAQ

What is the current stock price of Smith & Nephew (SNN)?

Smith & Nephew (SNN) last closed at $30.47.

What is the market cap of Smith & Nephew (SNN)?

The market cap of Smith & Nephew (SNN) is approximately $12.8B.